LP, H., KF, I., J, R., JH, K., & R, K. (2006). Transfer of reboxetine into breastmilk, its plasma concentrations and lack of adverse effects in the breastfed infant. European journal of clinical pharmacology, 62(8), 633. https://doi.org/10.1007/s00228-006-0140-0
Chicago Style (17th ed.) CitationLP, Hackett, Ilett KF, Rampono J, Kristensen JH, and Kohan R. "Transfer of Reboxetine into Breastmilk, Its Plasma Concentrations and Lack of Adverse Effects in the Breastfed Infant." European Journal of Clinical Pharmacology 62, no. 8 (2006): 633. https://doi.org/10.1007/s00228-006-0140-0.
MLA (9th ed.) CitationLP, Hackett, et al. "Transfer of Reboxetine into Breastmilk, Its Plasma Concentrations and Lack of Adverse Effects in the Breastfed Infant." European Journal of Clinical Pharmacology, vol. 62, no. 8, 2006, p. 633, https://doi.org/10.1007/s00228-006-0140-0.